scorecardresearch
Add as a preferred source on Google
Tuesday, March 31, 2026
TopicZydus

Topic: Zydus

SC declines to restrain Zydus from selling cancer drug biosimilar, tells Bristol Myers to approach HC

A bench headed by the Chief Justice of India suggests Squibb to conduct a mapping exercise of Zydus product with their claimed patent to ascertain infringement, if any.

ZyCoV-D could be India’s next Covid vaccine: Learn the science behind it & how it’s different

Zydus Cadila is expecting approval for India's second indigenously-developed vaccine by June. ThePrint explains how it works.

30,000 volunteers, 60 sites — India’s 3rd Covid vaccine candidate ZYCoV-D set for final trials

Zydus Cadila chief Pankaj Patel says ZYCoV-D is easy to store, transport and inject. It can also be produced in large quantities, in a ten-dose vial format.

On Camera

RBI delays stricter trading loan rules as volatility climbs amid Iran conflict

The rules now take effect on 1 July instead of 1 April, the Reserve Bank of India said. New rules may raise cost of raising capital for proprietary trading firms & squeeze profits.

More ‘hits’ than Rheinmetall ever—Ukraine drone manufacturer claps back at CEO’s ‘housewives’ remark

Oleksandr Yakovenko, founder of Ukrainian drone maker TAF Industries, further went on to highlight the growing 'irrelevance' of European defence platforms.

Gulf war exposed India’s fragilities. It’s time for navel-gazing, in the national interest

It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.